← SynDRA
ADATANSERIN
SynDRA canonical compound SYN0033719 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HTR2A |
|---|
| Mechanism of action | Serotonin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Serotonin receptor agonist
- Serotonin receptor antagonist
- HTR1A AGONIST
- HTR2A ANTAGONIST
Cross-references
Synonyms
- Adatanserine
- Adatanserina
- WY-50324
- Adatanserin [INN]
- WY 50324
- N-[2-(4-pyrimidin-2-ylpiperazin-1-yl)ethyl]adamantane-1-carboxamide
- adatanserina
- adatanserine
- W5U6WQM26H
- adatanserinum
- RefChem:109655
- DTXCID00200629
- UNII-W5U6WQM26H
- MLS006011548
- SCHEMBL247559
- orb1703828
- BDBM50083287
- BDBM50544115
- EBC-07337
- AKOS040745482
- SMR004703314
- HY-121053
- CS-0079368
- T23631
- EN300-1700020
- L001372
- SR-01000945138
- SR-01000945138-1
- BRD-K67789209-001-01-0
- Z749259376
- 阿达色林
- Adatanserin hydrochloride [USAN]
- WY-50324-HCL
- Adatanserin hcl
- UNII-48BX75B06D
- NS00122012
- DTXCID3085346
- SCHEMBL120908
Look up ADATANSERIN in the interactive SynDRA portal →